Objective:To assess the efficacy of gabapentin in the treatment of low back pain ***:This prospective observational study was conducted over 6 months to assess the efficacy of gabapentin in patients suffering from low...
详细信息
Objective:To assess the efficacy of gabapentin in the treatment of low back pain ***:This prospective observational study was conducted over 6 months to assess the efficacy of gabapentin in patients suffering from low back *** medical history,pain severity by Visual Analogue scale(VAS)and sleep quality by Pittsburgh Sleep Quality Index(PQSI)were *** scores and PQSI scores before and after gabapentin treatment were compared,and gabapentin satisfaction post treatment were ***:This study included 100 low back pain patients with 65 males and 35 females,and the mean age was(39.0±10.5)*** commonest presentation was non-radiating low back pain(40%).The mean VAS score and the mean PQSI score in the study before treatment were 7.70±1.91 and 10.95±5.02,*** treatment with gabapentin,the mean VAS score and the mean PQSI score decreased to 2.75±1.79 and 4.90±2.20,respectively,and the differences before and after the treatment were significantly different(both P=0.001).Overall,62%of the patients were extremely satisfied with gabapentin because they reported no adverse drug ***,31%of the patients were satisfied and 7%were strongly dissatisfied with the ***:Gabapentin can improve sleep quality and reduce lower back pain as measured by the VAS and *** efficacy of this drug is relatively good,but further improvement is required.
Purpose:Hip fractures among elderly patients are surgical *** COVID-19 pandemic time,many such patients could not be operated at early time because of the limitation of the medical resources,the risk of infection and ...
详细信息
Purpose:Hip fractures among elderly patients are surgical *** COVID-19 pandemic time,many such patients could not be operated at early time because of the limitation of the medical resources,the risk of infection and redirection of medical attention to a severe infective health ***:A search of electronic databases(PubMed,Medline,CINAHL,EMBASE and the Cochrane Central Register of Controlled Trials)with the keywords"COVID","COVID-19","SARS-COV-2","Corona","pandemic","hip fracture","trochanteric fracture"and"neck femur fracture"revealed 64 studies evaluating treatment of hip fracture in elderly patients during COVID-19 pandemic *** 30-day mortality rate,inpatient mortality rate,critical care/special care need,readmission rate and complications rate in both groups were *** were analyzed using Review Manager(RevMan)***:After screening,7 studies were identified that described the mortality and morbidity in hip fractures in both COVID-19 infected(COVID-19+)and non-infected(COVID-19-)*** were significantly increased risks of 30-day mortality(32.23%COVID-19+deathvs.8.85%COVID-19-death)and inpatient mortality(29.33%vs.2.62%)among COVID-19+patients with odds ratio(OR)of 4.84(95%CI:3.13-7.47,p<0.001)and 15.12(95%CI:6.12-37.37,p<0.001),*** COVID-19+patients needed more critical care admission(OR=5.08,95%CI:1.49-17.30,p<0.009)and they remain admitted for a longer time in hospital(mean difference=3.6,95% CI:1.74-5.45,p<0.001);but there was no difference in readmission rate between these 2 *** risks of overall complications(OR=17.22),development of pneumonia(OR=22.25),and acute respiratory distress syndrome/acute respiratory failure(OR=32.96)were significantly high among COVID-19+patients compared to ***:There are increased risks of the 30-day mortality,inpatient mortality and critical care admission among hip fracture patients who are COVID-19+.The chances of developing pn
暂无评论